HYP-6589

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameHYP-6589
Drug Alias NameHYP-6589HYP6589
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSon of sevenless homolog 1 inhibitors
TargetsSon of sevenless homolog 1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSichuan Huiyu Seacross Pharma Technology Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSichuan Huiyu Seacross Pharma Technology LtdSichuan Huiyu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A